{'fraction_non_alphanumeric': 0.03522504892367906, 'fraction_numerical': 0.007827788649706457, 'mean_word_length': 5.564102564102564, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Platelets, inflammation and anti-inflammatory drugs in ACS and CAD.

In this theme issue, which is based on the annual meeting of the European Platelet Academy (EPA) 2014 in Dresden, Germany (organiser: K. Schror), the authors aimed to present and discuss newest developments in an important topic, exciting also for its clinical relevance: The relationship between platelets, inflammation and anti-inflammatory agents. In the following paragraphs representing important subtopics we summarise recent knowledge.